Smilagenin and its use
US6258386A · kind A · utility
15Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 28, 1999 |
| Grant date | Jul 10, 2001 |
| Priority date | — |
| Expiry date | Jul 28, 2019 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N33/944
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention discloses the use of a smilagenin in the treatment of cognitive disfunction and similar conditions. Methods of treatment, and pharmaceutical compositions are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.